Skip to main content
Top

Experimental Hematology & Oncology

Issue 1/2018

Content (32 Articles)

WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia

  • Open Access
  • Research

Hongtao Liu, Yuanyuan Zha, Noura Choudhury, Gregory Malnassy, Noreen Fulton, Margaret Green, Jae-Hyun Park, Yusuke Nakamura, Richard A. Larson, Andres M. Salazar, Olatoyosi Odenike, Thomas F. Gajewski, Wendy Stock

Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib

  • Open Access
  • Case report

V. Sgroi, M. Bassanelli, M. Roberto, E. Iannicelli, R. Porrini, P. Pellegrini, A. Tafuri, P. Marchetti

Deep sustained response to daratumumab monotherapy associated with T-cell expansion in triple refractory myeloma

  • Open Access
  • Case report

Saad Z. Usmani, Imran Khan, Christopher Chiu, David Foureau, Lawrence J. Druhan, Katherine Rigby, Tineke Casneuf, A. Kate Sasser

Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States

  • Open Access
  • Research

Charles McCrea, Sukhvinder Johal, Shuo Yang, Justin Doan

Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies

  • Open Access
  • Rapid communication

Julien Magne, Alizée Jenvrin, Adrien Chauchet, Olivier Casasnovas, Anne Donzel, Laurence Jego, Bernard Aral, Julien Guy, Nathalie Nadal, Dewi Vernerey, Patrick Callier, Francine Garnache-Ottou, Christophe Ferrand

Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report

  • Open Access
  • Case report

D. E. Meyers, W. F. Hill, A. Suo, V. Jimenez-Zepeda, T. Cheng, N. A. Nixon

PAN3–PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia

  • Open Access
  • Case report

Ioannis Panagopoulos, Ludmila Gorunova, Hege Kilen Andersen, Astrid Bergrem, Anders Dahm, Kristin Andersen, Francesca Micci, Sverre Heim

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

  • Open Access
  • Research

Magnus Aassved Hjort, Håkon Hov, Pegah Abdollahi, Esten Nymoen Vandsemb, Unn-Merete Fagerli, Bendik Lund, Tobias Schmidt Slørdahl, Magne Børset, Torstein Baade Rø

Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia

  • Open Access
  • Research

Akiko Mita, Maiko Abumiya, Masatomo Miura, Takenori Niioka, Saori Takahashi, Tomoko Yoshioka, Yoshihiro Kameoka, Naoto Takahashi

An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer

  • Open Access
  • Rapid communication

Rafael Sebastián Fort, Cecilia Mathó, Carolina Oliveira-Rizzo, Beatriz Garat, José Roberto Sotelo-Silveira, María Ana Duhagon

Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature

  • Open Access
  • Case report

Shagufta Shaheen, Hamid Mirshahidi, Gayathri Nagaraj, Chung-Tsen Hsueh

Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma

  • Open Access
  • Research

Patrick B. Johnston, Lauren C. Pinter-Brown, Ghulam Warsi, Kristen White, Radhakrishnan Ramchandren

Understanding metabolic changes in aging bone marrow

  • Open Access
  • Research

Kwasi M. Connor, Young Hsu, Pardeep Kumar Aggarwal, Stephen Capone, Anthony R. Colombo, Giridharan Ramsingh

Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature

  • Open Access
  • Review

Armand Russo, Susanna Curtis, Raisa Balbuena-Merle, Roxanne Wadia, Ellice Wong, Herta H. Chao

Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data

  • Open Access
  • Research

Dilan Paranagama, Philomena Colucci, Kristin A. Evans, Machaon Bonafede, Shreekant Parasuraman

Emerging therapies in advanced hepatocellular carcinoma

  • Open Access
  • Review

Sowmini Medavaram, Yue Zhang

A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

  • Open Access
  • Research

Henrik Gregersen, Trung Do, Ida Bruun Kristensen, Ulf Christian Frølund, Niels Frost Andersen, Lene Kongsgaard Nielsen, Christen Lykkegaard Andersen, Tobias Wirenfeldt Klausen, Annette Juul Vangsted, Niels Abildgaard

The association of HLA-C alleles with multiple myeloma in Chinese patients

  • Open Access
  • Research

Xiaojing Wang, Gang An, Jiying Wang, Yan Zhang, Qinghua Li, Hui wei, Lugui Qiu, Kun Ru

Metastatic squamous cell carcinoma of the skin with clinical response to lapatinib

  • Open Access
  • Case report

John D. Strickley, Aaron C. Spalding, M. Tye Haeberle, Timothy Brown, Don A. Stevens, Jae Jung

Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma

  • Open Access
  • Case report

Elena V. Poddubskaya, Madina P. Baranova, Daria O. Allina, Philipp Y. Smirnov, Eugene A. Albert, Alexey P. Kirilchev, Alexey A. Aleshin, Marina I. Sekacheva, Maria V. Suntsova

Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin

  • Open Access
  • Research

Satish Maharaj, Simone Chang, Karan Seegobin, James Morales, Agnes Aysola, Fauzia Rana, Marwan Shaikh

Mechanisms for estrogen receptor expression in human cancer

  • Open Access
  • Review

Hui Hua, Hongying Zhang, Qingbin Kong, Yangfu Jiang

Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells

  • Open Access
  • Short report

Alejandro Pando, John L. Reagan, Martha Nevola, Loren D. Fast

Early detection of transformation to BPDCN in a patient with MDS

  • Open Access
  • Case report

Kamal Chamoun, Sanam Loghavi, Naveen Pemmaraju, Marina Konopleva, Michael Kroll, Madeleine Nguyen-Cao, Marisa Hornbaker, Courtney D. DiNardo, Tapan Kadia, Jeffrey Jorgensen, Michael Andreeff, Shimin Hu, Christopher B. Benton

Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth

  • Open Access
  • Research

Xun Ma, Sandy W. Wong, Ping Zhou, Chakra P. Chaulagain, Parul Doshi, Andreas K. Klein, Kellie Sprague, Adin Kugelmass, Denis Toskic, Melissa Warner, Kenneth B. Miller, Lisa Lee, Cindy Varga, Raymond L. Comenzo

The role of neoantigen in immune checkpoint blockade therapy

  • Open Access
  • Review

Ming Yi, Shuang Qin, Weiheng Zhao, Shengnan Yu, Qian Chu, Kongming Wu

Early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia

  • Open Access
  • Research

Wasil Jastaniah, Naglla Elimam, Khalid Abdalla, Aeshah A. AlAzmi, Aml M. Elgaml, Ahmad Alkassar, Mustafa Daghistani, Sami Felimban

Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine

  • Open Access
  • Review

Hanxiao Xu, Ying Jiao, Shuang Qin, Weiheng Zhao, Qian Chu, Kongming Wu

The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia

  • Open Access
  • Research

Yee Yee Yap, Kian Boon Law, Jameela Sathar, Ngee Siang Lau, Ai Sim Goh, Teng Keat Chew, Soo Min Lim, Padmini Menon, Yong Khee Guan, Azlan Bin Husin, Lily Lee Lee Wong, Lee Ping Chew, Sinari Salleh, Kim Yen Goh, Kin Wah Leong, Sen Mui Tan, Tee Chuan Ong, Su Hong Lim, See Guan Toh, Xavier Sim Yoon Han, Syed Carlo Edmund, Jenq Tzong Tan, Kian Meng Chang

Methylome of human senescent hematopoietic progenitors

  • Open Access
  • Research

Stephen Capone, Anthony R. Colombo, Benjamin K. Johnson, Tim J. Triche Jr., Giridharan Ramsingh

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now
Video